240 related articles for article (PubMed ID: 26867564)
21. Coactivator-associated arginine methyltransferase-1 enhances nuclear factor-kappaB-mediated gene transcription through methylation of histone H3 at arginine 17.
Miao F; Li S; Chavez V; Lanting L; Natarajan R
Mol Endocrinol; 2006 Jul; 20(7):1562-73. PubMed ID: 16497732
[TBL] [Abstract][Full Text] [Related]
22. Direct methylation of FXR by Set7/9, a lysine methyltransferase, regulates the expression of FXR target genes.
Balasubramaniyan N; Ananthanarayanan M; Suchy FJ
Am J Physiol Gastrointest Liver Physiol; 2012 May; 302(9):G937-47. PubMed ID: 22345554
[TBL] [Abstract][Full Text] [Related]
23. Tumor suppressor SMAR1 represses IkappaBalpha expression and inhibits p65 transactivation through matrix attachment regions.
Singh K; Sinha S; Malonia SK; Bist P; Tergaonkar V; Chattopadhyay S
J Biol Chem; 2009 Jan; 284(2):1267-78. PubMed ID: 18981184
[TBL] [Abstract][Full Text] [Related]
24. Bile acid nuclear receptor FXR and digestive system diseases.
Ding L; Yang L; Wang Z; Huang W
Acta Pharm Sin B; 2015 Mar; 5(2):135-44. PubMed ID: 26579439
[TBL] [Abstract][Full Text] [Related]
25. FXR regulates organic solute transporters alpha and beta in the adrenal gland, kidney, and intestine.
Lee H; Zhang Y; Lee FY; Nelson SF; Gonzalez FJ; Edwards PA
J Lipid Res; 2006 Jan; 47(1):201-14. PubMed ID: 16251721
[TBL] [Abstract][Full Text] [Related]
26. Promoter-dependent effect of IKKalpha on NF-kappaB/p65 DNA binding.
Gloire G; Horion J; El Mjiyad N; Bex F; Chariot A; Dejardin E; Piette J
J Biol Chem; 2007 Jul; 282(29):21308-18. PubMed ID: 17537731
[TBL] [Abstract][Full Text] [Related]
27. Ligand-dependent activation of the farnesoid X-receptor directs arginine methylation of histone H3 by CARM1.
Ananthanarayanan M; Li S; Balasubramaniyan N; Suchy FJ; Walsh MJ
J Biol Chem; 2004 Dec; 279(52):54348-57. PubMed ID: 15471871
[TBL] [Abstract][Full Text] [Related]
28. NF-κB Regulation of LRH-1 and ABCG5/8 Potentiates Phytosterol Role in the Pathogenesis of Parenteral Nutrition-Associated Cholestasis.
Ghosh S; Devereaux MW; Anderson AL; Gehrke S; Reisz JA; D'Alessandro A; Orlicky DJ; Lovell M; El Kasmi KC; Shearn CT; Sokol RJ
Hepatology; 2021 Dec; 74(6):3284-3300. PubMed ID: 34310734
[TBL] [Abstract][Full Text] [Related]
29. Transcriptional dynamics of bile salt export pump during pregnancy: mechanisms and implications in intrahepatic cholestasis of pregnancy.
Song X; Vasilenko A; Chen Y; Valanejad L; Verma R; Yan B; Deng R
Hepatology; 2014 Dec; 60(6):1993-2007. PubMed ID: 24729004
[TBL] [Abstract][Full Text] [Related]
30. Farnesoid X receptor antagonizes nuclear factor kappaB in hepatic inflammatory response.
Wang YD; Chen WD; Wang M; Yu D; Forman BM; Huang W
Hepatology; 2008 Nov; 48(5):1632-43. PubMed ID: 18972444
[TBL] [Abstract][Full Text] [Related]
31. Histone Deacetylase Inhibitor RGFP109 Overcomes Temozolomide Resistance by Blocking NF-κB-Dependent Transcription in Glioblastoma Cell Lines.
Li ZY; Li QZ; Chen L; Chen BD; Wang B; Zhang XJ; Li WP
Neurochem Res; 2016 Dec; 41(12):3192-3205. PubMed ID: 27632183
[TBL] [Abstract][Full Text] [Related]
32. Retinoid X receptor (RXR) agonist-induced antagonism of farnesoid X receptor (FXR) activity due to absence of coactivator recruitment and decreased DNA binding.
Kassam A; Miao B; Young PR; Mukherjee R
J Biol Chem; 2003 Mar; 278(12):10028-32. PubMed ID: 12519787
[TBL] [Abstract][Full Text] [Related]
33. 1alpha,25-Dihydroxyvitamin D3 inhibits transcriptional potential of nuclear factor kappa B in breast cancer cells.
Tse AK; Zhu GY; Wan CK; Shen XL; Yu ZL; Fong WF
Mol Immunol; 2010 May; 47(9):1728-38. PubMed ID: 20371119
[TBL] [Abstract][Full Text] [Related]
34. Inhibition of glyceroneogenesis by histone deacetylase 3 contributes to lipodystrophy in mice with adipose tissue inflammation.
Zhang J; Henagan TM; Gao Z; Ye J
Endocrinology; 2011 May; 152(5):1829-38. PubMed ID: 21406501
[TBL] [Abstract][Full Text] [Related]
35. 1,25-dihydroxyvitamin D3 and its receptor inhibit the chenodeoxycholic acid-dependent transactivation by farnesoid X receptor.
Honjo Y; Sasaki S; Kobayashi Y; Misawa H; Nakamura H
J Endocrinol; 2006 Mar; 188(3):635-43. PubMed ID: 16522742
[TBL] [Abstract][Full Text] [Related]
36. How glucocorticoid receptors modulate the activity of other transcription factors: a scope beyond tethering.
Ratman D; Vanden Berghe W; Dejager L; Libert C; Tavernier J; Beck IM; De Bosscher K
Mol Cell Endocrinol; 2013 Nov; 380(1-2):41-54. PubMed ID: 23267834
[TBL] [Abstract][Full Text] [Related]
37. Gene expression profiling in human precision cut liver slices in response to the FXR agonist obeticholic acid.
Ijssennagger N; Janssen AWF; Milona A; Ramos Pittol JM; Hollman DAA; Mokry M; Betzel B; Berends FJ; Janssen IM; van Mil SWC; Kersten S
J Hepatol; 2016 May; 64(5):1158-1166. PubMed ID: 26812075
[TBL] [Abstract][Full Text] [Related]
38. Geniposidic acid protected against ANIT-induced hepatotoxity and acute intrahepatic cholestasis, due to Fxr-mediated regulation of Bsep and Mrp2.
Chen H; Huang X; Min J; Li W; Zhang R; Zhao W; Liu C; Yi L; Mi S; Wang N; Wang Q; Zhu C
J Ethnopharmacol; 2016 Feb; 179():197-207. PubMed ID: 26723467
[TBL] [Abstract][Full Text] [Related]
39. Identification of a negative regulatory cis-element in the enhancer core region of the prostate-specific antigen promoter: implications for intersection of androgen receptor and nuclear factor-kappaB signalling in prostate cancer cells.
Cinar B; Yeung F; Konaka H; Mayo MW; Freeman MR; Zhau HE; Chung LW
Biochem J; 2004 Apr; 379(Pt 2):421-31. PubMed ID: 14715080
[TBL] [Abstract][Full Text] [Related]
40. Role of nuclear bile acid receptor, FXR, in adaptive ABC transporter regulation by cholic and ursodeoxycholic acid in mouse liver, kidney and intestine.
Zollner G; Fickert P; Fuchsbichler A; Silbert D; Wagner M; Arbeiter S; Gonzalez FJ; Marschall HU; Zatloukal K; Denk H; Trauner M
J Hepatol; 2003 Oct; 39(4):480-8. PubMed ID: 12971955
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
